Details of Drug

Drug General Information (ID: D1483)
Drug Name	Sodium citrate
Drug Type	Small molecule
Drug Synonymous	Sodium citrate; 68-04-2; TRISODIUM CITRATE; Citrosodine; Sodium citrate anhydrous; Citrosodina; Natrocitral; Citrosodna; Citreme; Citnatin; sodium citrate, anhydrous; Sodium 2-hydroxypropane-1,2,3-tricarboxylate; Trisodium citrate anhydrous; Citric acid, trisodium salt; Trisodium citrate, anhydrous; Citric acid trisodium salt; 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, trisodium salt; UNII-RS7A450LGA; FEMA No. 3026; CCRIS 3293; Sodium citrate (Na3C6H5O7); HSDB 5201; EINECS 200-675-3; RS7A450LGA; CHEBI:53258; Trisodium 2-hydroxy-1 Click to Show/Hide
Therapeutic Class	Minerals And Electrolytes
Structure
Structure	3D Structure		2D Structure
Formula	C6H5Na3O7
InChI	1S/C6H8O7.3Na/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;/q;3*+1/p-3
InChIKey	HRXKRNGNAMMEHJ-UHFFFAOYSA-K
Canonical SMILES	C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]
External Link
	Pubchem ID	6224
	CAS Number	24930
	CHEBI ID	53258
	TTD ID	D05KTE

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM005 Affected excretion pathways BM001 Altered gastrointestinal dynamics BM003 Complex formation BM005 Altered gastric pH BM029 Altered urine pH
Relation Graph

Full list of drugs interacting with Sodium citrate
Affected gastrointestinal absorption
	Altered gastrointestinal dynamics					Drug Num: 15
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0045		Alprazolam	C17H13ClN4	2118	Minor		Inter Info	[76], [77], [78], [79], [80], [81], [82], [83], [84]
D0317		Chlordiazepoxide	C16H14ClN3O	2712	Minor		Inter Info	[76], [77], [78], [79], [80], [81], [82], [83], [84]
D0356		Clobazam	C16H13ClN2O2	2789	Minor		Inter Info	[76], [77], [78], [79], [80], [81], [82], [83], [84]
D0362		Clonazepam	C15H10ClN3O3	2802	Minor		Inter Info	[76], [77], [78], [79], [80], [81], [82], [83], [84]
D0365		Clorazepic acid	C16H11ClN2O3	2809	Minor		Inter Info	[77], [78], [81]
D0473		Diazepam	C16H13ClN2O	3016	Minor		Inter Info	[76], [77], [78], [79], [80], [81], [82], [83], [84]
D0604		Estazolam	C16H11ClN4	3261	Minor		Inter Info	[76], [77], [78], [79], [80], [81], [82], [83], [84]
D0679		Flurazepam	C21H23ClFN3O	3393	Minor		Inter Info	[76], [77], [78], [79], [80], [81], [82], [83], [84]
D0748		Halazepam	C17H12ClF3N2O	31640	Minor		Inter Info	[76], [77], [78], [79], [80], [81], [82], [83], [84]
D0951		Lorazepam	C15H10Cl2N2O2	3958	Minor		Inter Info	[76], [77], [78], [79], [80], [81], [82], [83], [84]
D1060		Midazolam	C18H13ClFN3	4192	Minor		Inter Info	[76], [77], [78], [79], [80], [81], [82], [83], [84]
D1197		Oxazepam	C15H11ClN2O2	4616	Minor		Inter Info	[76], [77], [78], [79], [80], [81], [82], [83], [84]
D1367		Quazepam	C17H11ClF4N2S	4999	Minor		Inter Info	[76], [77], [78], [79], [80], [81], [82], [83], [84]
D1547		Temazepam	C16H13ClN2O2	5391	Minor		Inter Info	[76], [77], [78], [79], [80], [81], [82], [83], [84]
D1632		Triazolam	C17H12Cl2N4	5556	Minor		Inter Info	[76], [77], [78], [79], [80], [81], [82], [83], [84]
	Complex formation					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0049		Aluminum hydroxide	AlH3O3	10176082	Major		Inter Info	[1]
D0490		Digitoxin	C41H64O13	441207	Minor		Inter Info	[87], [88], [89], [90], [91], [92], [93], [94], [95]
D0491		Digoxin	C41H64O14	2724385	Minor		Inter Info	[87], [88], [89], [90], [91], [92], [93], [94], [95]
	Altered gastric pH					Drug Num: 39
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0080		Amprenavir	C25H35N3O6S	65016	Moderate		Inter Info	[11], [12]
D0116		Atazanavir	C38H52N6O7	148192	Moderate		Inter Info	[13], [14], [15]
D0141		Bacampicillin	C21H27N3O7S	441397	Moderate		Inter Info	[16], [17]
D0195		Bosutinib	C26H29Cl2N5O3	5328940	Moderate		Inter Info	[1], [18]
D0278		Cefditoren	C19H18N6O5S3	9870843	Moderate		Inter Info	[19]
D0288		Cefpodoxime	C15H17N5O6S2	6335986	Moderate		Inter Info	[16], [20], [21], [17]
D0297		Cefuroxime	C16H16N4O8S	5479529	Moderate		Inter Info	[16], [20], [21], [17]
D0302		Ceritinib	C28H36ClN5O3S	57379345	Moderate		Inter Info	[22]
D0406		Dabrafenib	C23H20F3N5O2S2	44462760	Moderate		Inter Info	[25], [1], [26], [27], [28], [29], [30]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Moderate		Inter Info	[31]
D0595		Erlotinib	C22H23N3O4	176870	Moderate		Inter Info	[25], [1], [38], [39]
D0898		Ledipasvir	C49H54F2N8O6	67505836	Moderate		Inter Info	[40]
D1094		Mycophenolate mofetil	C23H31NO7	5281078	Moderate		Inter Info	[48], [49], [50], [51]
D1095		Mycophenolic acid	C17H20O6	446541	Moderate		Inter Info	[48], [49], [50], [51]
D1136		Nilotinib	C28H22F3N7O	644241	Moderate		Inter Info	[25], [1]
D1232		Pazopanib	C21H23N7O2S	10113978	Moderate		Inter Info	[1], [52], [53], [54], [55], [56]
D1404		Rilpivirine	C22H18N6	6451164	Moderate		Inter Info	[60]
D1408		Riociguat	C20H19FN8O2	11304743	Moderate		Inter Info	[61]
D1430		Rosuvastatin	C22H28FN3O6S	446157	Moderate		Inter Info	[62]
D0008		Acalabrutinib	C26H23N7O2	71226662	Moderate		Inter Info	[65]
D0229		Cabotegravir	C19H17F2N3O5	54713659	Moderate		Inter Info	[66]
D1124		Neratinib	C30H29ClN6O3	9915743	Moderate		Inter Info	[70]
D1258		Pexidartinib	C20H15ClF3N5	25151352	Moderate		Inter Info	[71]
D1686		Velpatasvir	C49H54N8O8	67683363	Moderate		Inter Info	[72]
D1592		Tipranavir	C31H33F3N2O5S	54682461	Moderate		Inter Info	[73], [15]
D0133		Axitinib	C22H18N4OS	6450551	Minor		Inter Info	[85]
D0156		Benazepril	C24H28N2O5	5362124	Minor		Inter Info	[86]
D0254		Captopril	C9H15NO3S	44093	Minor		Inter Info	[86]
D0539		Duloxetine	C18H19NOS	60835	Minor		Inter Info	[96]
D0567		Enalapril	C20H28N2O5	5388962	Minor		Inter Info	[86]
D0695		Fosinopril	C30H46NO7P	55891	Minor		Inter Info	[86]
D0938		Lisinopril	C21H31N3O5	5362119	Minor		Inter Info	[86]
D1082		Moexipril	C27H34N2O7	91270	Minor		Inter Info	[86]
D1256		Perindopril	C19H32N2O5	107807	Minor		Inter Info	[86]
D1313		Ponatinib	C29H27F3N6O	24826799	Minor		Inter Info	[25], [101]
D1369		Quinapril	C25H30N2O5	54892	Minor		Inter Info	[86]
D1379		Ramipril	C23H32N2O5	5362129	Minor		Inter Info	[86]
D1618		Trandolapril	C24H34N2O5	5484727	Minor		Inter Info	[86]
D1701		Vismodegib	C19H14Cl2N2O3S	24776445	Minor		Inter Info	[25], [1], [102]
Affected excretion pathways
	Altered urine pH					Drug Num: 41
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0017		Acetylsalicylic acid	C9H8O4	2244	Moderate		Inter Info	[2], [3], [4]
D0074		Amphetamine	C9H13N	3007	Moderate		Inter Info	[5], [6], [7], [8], [9], [10]
D0165		Benzphetamine	C17H21N	5311017	Moderate		Inter Info	[5], [6], [7], [8], [9], [10]
D0340		Cinoxacin	C12H10N2O5	2762	Moderate		Inter Info	[23], [24]
D0341		Ciprofloxacin	C17H18FN3O3	2764	Moderate		Inter Info	[23], [24]
D0441		Demeclocycline	C21H21ClN2O8	54680690	Moderate		Inter Info	[32], [33], [34]
D0465		Dextroamphetamine	C9H13N	5826	Moderate		Inter Info	[5], [6], [7], [8], [9], [10]
D0573		Enoxacin	C15H17FN4O3	3229	Moderate		Inter Info	[23], [24]
D0579		Ephedrine	C10H15NO	9294	Moderate		Inter Info	[35], [36], [37]
D0580		Ephedrine (nasal)	C10H15NO	9294	Moderate		Inter Info	[35], [36], [37]
D0712		Gatifloxacin	C19H22FN3O4	5379	Moderate		Inter Info	[23], [24]
D0740		Grepafloxacin	C19H22FN3O3	72474	Moderate		Inter Info	[23], [24]
D0919		Levofloxacin	C18H20FN3O4	149096	Moderate		Inter Info	[23], [24]
D0937		Lisdexamfetamine	C15H25N3O	11597698	Moderate		Inter Info	[5], [6], [7], [8], [9], [10]
D0943		Lomefloxacin	C17H19F2N3O3	3948	Moderate		Inter Info	[23], [24]
D0983		Mecamylamine	C11H21N	4032	Moderate		Inter Info	[41]
D1012		Metamfetamine	C10H15N	10836	Moderate		Inter Info	[5], [9], [10]
D1020		Methenamine	C6H12N4	4101	Moderate		Inter Info	[42], [43], [44], [45], [46]
D1054		Mexiletine	C11H17NO	4178	Moderate		Inter Info	[47]
D1070		Minocycline	C23H27N3O7	54675783	Moderate		Inter Info	[32], [33], [34]
D1092		Moxifloxacin	C21H24FN3O4	152946	Moderate		Inter Info	[23], [24]
D1102		Nalidixic acid	C12H12N2O3	4421	Moderate		Inter Info	[23], [24]
D1155		Norfloxacin	C16H18FN3O3	4539	Moderate		Inter Info	[23], [24]
D1165		Ofloxacin	C18H20FN3O4	4583	Moderate		Inter Info	[23], [24]
D1209		Oxytetracycline	C22H24N2O9	54675779	Moderate		Inter Info	[32], [33], [34]
D1363		Pseudoephedrine	C10H15NO	7028	Moderate		Inter Info	[35], [36], [37]
D1371		Quinidine	C20H24N2O2	441074	Moderate		Inter Info	[57], [58], [59]
D1442		Salsalate	C14H10O5	5161	Moderate		Inter Info	[63], [64], [2], [3], [4]
D0331		Choline salicylate	C12H19NO4	54686350	Moderate		Inter Info	[63], [64], [2], [3], [4]
D0940		Lithium carbonate	CLi2O3	11125	Moderate		Inter Info	[67], [68], [69]
D1564		Tetracycline	C22H24N2O8	54675776	Moderate		Inter Info	[32], [33], [34]
D1657		Trovafloxacin	C20H15F3N4O3	62959	Moderate		Inter Info	[23], [24]
D0013		Acetohexamide	C15H20N2O4S	1989	Minor		Inter Info	[74], [75]
D0325		Chlorpropamide	C10H13ClN2O3S	2727	Minor		Inter Info	[74], [75]
D0664		Flecainide	C17H20F6N2O3	3356	Minor		Inter Info	[97]
D0728		Glipizide	C21H27N5O4S	3478	Minor		Inter Info	[74], [75]
D0730		Glyburide	C23H28ClN3O5S	3488	Minor		Inter Info	[74], [75]
D0998		Memantine	C12H21N	4054	Minor		Inter Info	[98]
D1025		Methotrexate	C20H22N8O5	126941	Minor		Inter Info	[99], [46], [100]
D1601		Tolazamide	C14H21N3O3S	5503	Minor		Inter Info	[74], [75]
D1603		Tolbutamide	C12H18N2O3S	5505	Minor		Inter Info	[74], [75]

References
1	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
2	Berg KJ "Acute effects of acetylsalicylic acid in patients with chronic renal insufficiency." Eur J Clin Pharmacol 11 (1977): 111-6. [PMID: 837963]
3	Brouwers JRBJ, Desmet PAGM "Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs." Clin Pharmacokinet 27 (1994): 462-85. [PMID: 7882636]
4	Prescott LF, Balali-Mood M, Critchley JA, Johnstone AF, Proudfoot AT "Diuresis or urinary alkalinisation for salicylate poisoning?" Br Med J (Clin Res Ed) 285 (1982): 1383-6. [PMID: 6291695]
5	Anggard E, Jonsson LE, Hogmark AL, Gunne LM "Amphetamine metabolism in amphetamine psychosis." Clin Pharmacol Ther 14 (1973): 870-80. [PMID: 4729903]
6	Beckett AH, Rowland M "Urinary excretion kinetics of amphetamine in man." J Pharm Pharmacol 17 (1965): 628-39. [PMID: 4379686]
7	Beckett AH, Rowland M, Turner P "Influence of urinary pH on excretion of amphetamine." Lancet 1 (1965): 303. [PMID: 14247879]
8	Beckett AH, Salmon JA, Mitchard M "The relation between blood levels and urinary excretion of amphetamine under controlled acidic and under fluctuating urinary pH values using [C]amphetamine." J Pharm Pharmacol 21 (1969): 251-8. [PMID: 4390145]
9	Davis JM, Kopin IJ, Lemberger L, Axelrod J "Effects of urinary pH on amphetamine metabolism." Ann N Y Acad Sci 179 (1971): 493-501. [PMID: 5285389]
10	Wilkinson GR, Beckett AH "Absorption, metabolism and excretion of the ephedrines in man. I. The influence of urinary pH and urine volume output." J Pharmacol Exp Ther 162 (1968): 139-47. [PMID: 5656593]
11	Product Information. Agenerase (amprenavir). Glaxo Wellcome, Research Triangle Pk, NC.
12	Product Information. Lexiva (fosamprenavir). GlaxoSmithKline, Research Triangle Park, NC.
13	Product Information. Reyataz (atazanavir). Bristol-Myers Squibb, Princeton, NJ.
14	Ray JE, Marriott D, Bloch MT, McLachlan AJ "Therapeutic drug monitoring of atazanavir: surveillance of pharmacotherapy in the clinic." Br J Clin Pharmacol 60 (2005): 291-9. [PMID: 16120068]
15	Durant J, Clevenbergh P, Garraffo R, Halfon P, Icard S, DelGiudice P, Montagne N, Schapiro JM, Dellamonica P "Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study." Aids 14 (2000): 1333-9. [PMID: 10930147]
16	Honig PK, Gillespie BK "Clinical significance of pharmacokinetic drug interactions with over-the-counter (OTC) drugs." Clin Pharmacokinet 35 (1998): 167-71. [PMID: 9784931]
17	Sommers DK, van Wyk M, Moncrieff J, Schoeman HS "Influence of food and reduced gastric acidity on the bioavailability of bacampicillin and cefuroxime axetil." Br J Clin Pharmacol 18 (1984): 535-9. [PMID: 6091711]
18	Product Information. Bosulif (bosutinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
19	Product Information. Spectracef (cefditoren). TAP Pharmaceuticals Inc, Deerfield, IL.
20	Hughes GS, Heald DL, Barker KB, et al. "The effects of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil." Clin Pharmacol Ther 46 (1989): 674-85. [PMID: 2557183]
21	Saathoff N, Lode H, Neider K, et al "Pharmacokinetics of cefpodoxime and interactions with an antacid and an H2 receptor antagonist." Antimicrob Agents Chemother 36 (1992): 796-800. [PMID: 1354432]
22	Product Information. Zykadia (ceritinib). Novartis Pharmaceuticals, East Hanover, NJ.
23	Multum Information Services, Inc. Expert Review Panel.
24	Product Information. Cipro (ciprofloxacin). Bayer, West Haven, CT.
25	Cerner Multum, Inc. "Australian Product Information.".
26	Product Information. Aciphex (rabeprazole) Janssen Pharmaceuticals, Titusville, NJ.
27	Product Information. Dexilant (dexlansoprazole). Takeda Pharmaceuticals America, Lincolnshire, IL.
28	Product Information. Prevacid (lansoprazole). TAP Pharmaceuticals Inc, Deerfield, IL.
29	Product Information. Tafinlar (dabrafenib). GlaxoSmithKline, Research Triangle Park, NC.
30	Product Information. Zantac (ranitidine). Glaxo Wellcome, Research Triangle Park, NC.
31	Product Information. Sprycel (dasatinib). Bristol-Myers Squibb, Princeton, NJ.
32	Elliott GR "Sodium bicarbonate and oral tetracycline." Clin Pharmacol Ther 13 (1972): 459. [PMID: 5026384]
33	Jaffe JM, Colaizzi JI, Poust RI, McDonald RH Jr "Effect of altered urinary pH on tetracycline and doxycycline excretion in humans." J Pharmacokinet Biopharm 1 (1973): 267-82.
34	Jaffe JM, Poust RI, Feld SL, Colaizzi JL "Influence of repetitive dosing and altered urinary pH on doxycycline excretion in humans." J Pharm Sci 63 (1974): 1256-60. [PMID: 4852448]
35	Brater DC, Kaojarern S, Benet LZ, et al "Renal excretion of pseudoephedrine." Clin Pharmacol Ther 28 (1980): 690-4. [PMID: 7438686]
36	Kuntzman RG, Tsai I, Brand L, Mark LC "The influence of urinary pH on the plasma half-life of pseudoephedrine in man and dog and a sensitive assay for its determination in human plasma." Clin Pharmacol Ther 12 (1971): 62-7. [PMID: 5541135]
37	Wilkinson GR, Beckett AH "Absorption metabolism and excretion of the ephedrines in man. I. The influence of urinary pH and urine volume output." J Pharmacol Exp Ther 162 (1968): 139-47. [PMID: 5656593]
38	Duong S, Leung M "Should the concomitant use of erlotinib and acid-reducing agents be avoided? The drug interaction between erlotinib and acid-reducing agents." J Oncol Pharm Pract 17 (2011): 448-52. [PMID: 20716581]
39	Product Information. Tarceva (erlotinib). Genentech, South San Francisco, CA.
40	Product Information. Harvoni (ledipasvir-sofosbuvir). Gilead Sciences, Foster City, CA.
41	Allanby KD, Trounce JR "Excretion of mecamylamine after intravenous and oral administration." Br Med J 2 (1957): 1219-21. [PMID: 13472094]
42	Kevorkian C, Merritt J, Ilstrup D "Methenamine mandelate with acidification: an effective urinary antiseptic in patients with neurogenic bladder." Mayo Clin Proc 59 (1984): 523. [PMID: 6379319]
43	Musher D, Griffith D "Generation of formaldehyde from methenamine: effect of pH and concentration, and antibacterial effect." Antimicrob Agents Chemother 6 (1974): 708-11. [PMID: 4451344]
44	Product Information. Hiprex (methenamine). Hoechst Marion-Roussel Inc, Kansas City, MO.
45	Product Information. Hyophen (benzoic acid/hyoscy/methen/mblue/phenylsal). BioComp Pharma, San Antonio, TX.
46	Sand TE, Jacobsen S "Effect of urine pH and flow on renal clearance of methotrexate." Eur J Clin Pharmacol 19 (1981): 453-6. [PMID: 7250179]
47	Mitchell BG, Clements JA, Pottage A, Prescott LF "Mexiletine disposition: individual variation in response to urine acidification and alkalinisation." Br J Clin Pharmacol 16 (1983): 281-4. [PMID: 6626420]
48	Bullingham R, Shah J, Goldblum R, Schiff M "Effects of food and antacid on the pharmacokinetics of single doses of mycophenolate mofetil in rheumatoid arthritis patients." Br J Clin Pharmacol 41 (1996): 513-6. [PMID: 8799515]
49	Lipsky JJ "Mycophenolate mofetil." Lancet 348 (1996): 1357-9. [PMID: 8918281]
50	Product Information. CellCept (mycophenolate mofetil). Roche Laboratories, Nutley, NJ.
51	Product Information. Myfortic (mycophenolic acid). Novartis Pharmaceuticals, East Hanover, NJ.
52	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
53	Product Information. Votrient (pazopanib). GlaxoSmithKline, Research Triangle Park, NC.
54	Tan AR, Gibbon DG, Stein MN, et al. "Effects of ketoconazole and esomeprazole on the pharmacokinetics of pazopanib in patients with solid tumors." Cancer Chemother Pharmacol 71 (2013): 1635-43. [PMID: 23636448]
55	van Leeuwen RW, van Gelder T, Mathijssen RH, Jansman FG "Drug-drug interactions with tyrosine-kinase inhibitors: a clinical perspective." Lancet Oncol 15 (2014): e315-e326. [PMID: 24988935]
56	Yu G, Zheng QS, Wang DX, Zhou HH, Li GF "Drug interactions between tyrosine-kinase inhibitors and acid suppressive agents: more than meets the eye." Lancet Oncol 15 (2014): e469-70. [PMID: 25281461]
57	Ace LN, Jaffe JM, Kunka RL "Effect of food and an antacid on quinidine bioavailability." Biopharm Drug Dispos 4 (1983): 183-90. [PMID: 6882885]
58	Romankiewicz JA, Reidenberg M, Drayer D, Franklin JE "The noninterference of aluminum hydroxide gel with quinidine sulfate absorption: An approach to control quinidine-induced diarrhea." Am Heart J 96 (1978): 518-20
59	Mauro VF, Mauro LS, Fraker TD Jr, Temesy-Armos PN, Somani P "Effect of aluminum hydroxide gel on quinidine gluconate absorption." DICP 24 (1990): 252-4
60	Product Information. Edurant (rilpivirine). Tibotec Pharmaceuticals, Titusville, NJ.
61	Product Information. Adempas (riociguat). Bayer Pharmaceutical Inc, West Haven, CT.
62	Product Information. Crestor (rosuvastatin). AstraZeneca Pharma Inc, Mississauga, ON.
63	Balali-Mood M, Prescott LF "Failure of alkaline diuresis to enhance diflunisal elimination." Br J Clin Pharmacol 10 (1980): 163-5. [PMID: 7426277]
64	Berg KJ "Acute acetylsalicylic acid poisoning: treatment with forced alkaline diuresis and diuretics." Eur J Clin Pharmacol 12 (1977): 111-6. [PMID: 21797]
65	Product Information. Calquence (acalabrutinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
66	Cerner Multum, Inc. "Canadian Product Information.".
67	Parfrey PS, Ikeman R, Anglin D, Cole C. Severe lithium intoxication treated by forced diuresis. Can Med Assoc J. 1983 Nov 1;129(9):979-80
68	Arthur RK "Lithium levels and "Soda Bic"." Med J Aust 2 (1975): 918
69	Thomsen K, Schou M "Renal lithium excretion in man." Am J Psychol 215 (1968): 823-7
70	Product Information. Nerlynx (neratinib). Puma Biotechnology, Inc., Los Angeles, CA.
71	Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
72	Product Information. Epclusa (sofosbuvir-velpatasvir). Gilead Sciences, Foster City, CA.
73	Product Information. Aptivus (tipranavir). Boehringer-Ingelheim, Ridgefield, CT.
74	Kivisto KT, Neuvonen PJ "Differential effects of sodium bicarbonate and aluminium hydroxide on the absorption and activity of glipizide." Eur J Clin Pharmacol 40 (1991): 383-6. [PMID: 1646724]
75	Neuvonen PJ, Karkkainen S "Effects of charcoal, sodium bicarbonate, and ammonium chloride on chlorpropamide kinetics." Clin Pharmacol Ther 33 (1983): 386-93. [PMID: 6297841]
76	Chun AH, Carrigan PJ, Hoffman DJ, Kershner RP, Stuart JD "Effect of antacids on absorption of clorazepate." Clin Pharmacol Ther 22 (1977): 329-35. [PMID: 19188]
77	Greenblatt DJ, Allen MD, MacLaughlin DS, Harmatz JS, Shader RI "Diazepam absorption: effect of antacids and food." Clin Pharmacol Ther 24 (1978): 600-9. [PMID: 699484]
78	Greenblatt DJ, Shader RI, Harmatz JS, Franke K, Koch-Weser J "Absorption rate, blood concentrations, and early response to oral chlordiazepoxide." Am J Psychiatry 134 (1977): 559-62. [PMID: 848586]
79	Greenblatt DJ, Shader RI, Harmatz JS, Franke K, Koch-Weser J "Influence of magnesium and aluminum hydroxide mixture on chlordiazepoxide absorption." Clin Pharmacol Ther 19 (1976): 234-9. [PMID: 770046]
80	Kroboth PD, Smith RB, Rault R, Silver MR, Sorkin MI, Puschett JB, Juhl RP "Effects of end-stage renal disease and aluminum hydroxide on temazepam kinetics." Clin Pharmacol Ther 37 (1985): 453-9. [PMID: 2858279]
81	Kroboth PD, Smith RB, Silver MR, Rault R, Sorkin MI, Puschett JB, Juhl RP "Effects of end stage renal disease and aluminium hydroxide on triazolam pharmacokinetics." Br J Clin Pharmacol 19 (1985): 839-42. [PMID: 2862896]
82	Nair SG, Gamble JA, Dundee JW, Howard PJ "The influence of three antacids on the absorption and clinical action of oral diazepam." Br J Anaesth 48 (1976): 1175-80. [PMID: 1023953]
83	Shader RI, Ciraulo DA, Greenblatt DJ, Harmatz JS "Steady-state plasma desmethyldiazepam during long-term clorazepate use: effects of antacids." Clin Pharmacol Ther 31 (1982): 180-3. [PMID: 6120059]
84	Shader RI, Georgotas A, Greenblatt DJ, Harmatz JS, Allen MD "Impaired absorption of desmethyldiazepam from clorazepate by magnesium aluminum hydroxide." Clin Pharmacol Ther 24 (1978): 308-15. [PMID: 28870]
85	Product Information. Inlyta (axitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
86	Mantyla R, Mannisto PT, Vuorela A, Sundberg S, Ottoila P "Impairment of captopril bioavailability by concomitant food and antacid intake." Int J Clin Pharmacol Ther Toxicol 22 (1984): 626-9. [PMID: 6389377]
87	Allen MD, Greenblatt DJ, Harmatz JS, Smith TW "Effect of magnesium--aluminum hydroxide and kaolin--pectin on absorption of digoxin from tablets and capsules." J Clin Pharmacol 21 (1981): 26-30. [PMID: 7012189]
88	Bonelli J, Hruby K, Magometschnigg D, Hitzenberger G, Kaik G "The bio-availability of beta-acetyldigoxine alone and combined with aluminum hydroxide and magnesium hydroxide (Alucol)." Int J Clin Pharmacol Biopharm 15 (1977): 337-9. [PMID: 892951]
89	Brown DD, Juhl RP "Decreased bioavailability of digoxin due to antacids and kaolin-pectin." N Engl J Med 295 (1976): 1034-7. [PMID: 972657]
90	D'Arcy PF, McElnay JC "Drug-antacid interactions: assessment of clinical importance." Drug Intell Clin Pharm 21 (1987): 607-17. [PMID: 2886325]
91	Marcus FI "Pharmacokinetic interactions between digoxin and other drugs." J Am Coll Cardiol 5 (1985): a82-90. [PMID: 2985676]
92	McElnay JC, Harron DW, D'Arcy PF, Eagle MR "Interaction of digoxin with antacid constituents." Br Med J 1 (1978): 1554. [PMID: 656806]
93	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
94	Rodin SM, Johnson BF "Pharmacokinetic interactions with digoxin." Clin Pharmacokinet 15 (1988): 227-44. [PMID: 3056649]
95	Liu F, Qiu M, Zhai SD. Tolerability and effectiveness of (S)-amlodipine compared with racemic amlodipine in hypertension: a systematic review and meta-analysis.?Curr Ther Res Clin Exp. 2010;71(1):1-29. [PMID: 24683248]
96	Product Information. Cymbalta (duloxetine). Lilly, Eli and Company, Indianapolis, IN.
97	Hertrampf R, Gundert-Remy U, Beckmann J, et al "Elimination of flecainide as a function of urinary flow rate and pH." Eur J Clin Pharmacol 41 (1991): 61-3. [PMID: 1782979]
98	Product Information. Namenda (memantine). Forest Pharmaceuticals, St. Louis, MO.
99	Nirenberg A, Mosende C, Mehta BM, Gisolfi AL, Rosen G "High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity." Cancer Treat Rep 61 (1977): 779-83. [PMID: 302143]
100	Stoller RG, Hande KR, Jacobs SA, Rosenberg SA, Chabner BA "Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity." N Engl J Med 297 (1977): 630-4. [PMID: 302412]
101	Product Information. Iclusig (ponatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
102	Product Information. Erivedge (vismodegib). Genentech, South San Francisco, CA.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence